Cholangiocarcinoma (CCA) includes a heterogeneous group of malignancies arising from the biliary epithelium, anatomically classified into intrahepatic, perihilar, and distal disease, with subtype-specific molecular features and treatment implications. Intrahepatic CCA is further subclassified into small- and large-duct...
F. Saj, C. B. Xavier, L. Goyal et al.· JCO Oncology Practice· 0 citations
In a large cohort of patients with de novo mPDAC, more than half of patients were untreated or unable to tolerate CTx, possibly related to older age and worse PS, and this findings highlight a significant need for improved treatment options for mPDAC.
Shubham Pant, P. Pradhan, Yue-Xi Wang et al.· Cancer Research· 0 citations
Despite shared genomic drivers with PDAC, ASQ exhibits transcriptionally distinct features with spatially organized tumor and immune heterogeneity, supporting the need for subtype-specific therapeutic strategies.
S. Haldar, Meredith Wetzel, Jia-Yun Lu et al.· Clinical Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.